A Study Comparing the Efficacy of Long-acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder
Clinical trial NCT00236457 · COMPLETED
Trial details
- NCT number
- NCT00236457
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2000-11-01
- Enrollment
- 629
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.